268 related articles for article (PubMed ID: 19450840)
1. Metastatic renal cell carcinoma risk according to tumor size.
Thompson RH; Hill JR; Babayev Y; Cronin A; Kaag M; Kundu S; Bernstein M; Coleman J; Dalbagni G; Touijer K; Russo P
J Urol; 2009 Jul; 182(1):41-5. PubMed ID: 19450840
[TBL] [Abstract][Full Text] [Related]
2. Metastatic potential of a renal mass according to original tumour size at presentation.
Umbreit EC; Shimko MS; Childs MA; Lohse CM; Cheville JC; Leibovich BC; Blute ML; Thompson RH
BJU Int; 2012 Jan; 109(2):190-4; discussion 194. PubMed ID: 21557795
[TBL] [Abstract][Full Text] [Related]
3. Characteristics and prognosis of chromophobe non-metastatic renal cell carcinoma: a multicenter study.
Lee WK; Byun SS; Kim HH; Rha KH; Hwang TK; Sung GT; Lee W; Lim JS; Jeong YB; Kwon TG
Int J Urol; 2010 Nov; 17(11):898-904. PubMed ID: 20969636
[TBL] [Abstract][Full Text] [Related]
4. Outcomes following partial nephrectomy by tumor size.
Crispen PL; Boorjian SA; Lohse CM; Sebo TS; Cheville JC; Blute ML; Leibovich BC
J Urol; 2008 Nov; 180(5):1912-7. PubMed ID: 18801543
[TBL] [Abstract][Full Text] [Related]
5. Lack of retroperitoneal lymphadenopathy predicts survival of patients with metastatic renal cell carcinoma.
Vasselli JR; Yang JC; Linehan WM; White DE; Rosenberg SA; Walther MM
J Urol; 2001 Jul; 166(1):68-72. PubMed ID: 11435825
[TBL] [Abstract][Full Text] [Related]
6. Association of microvascular and capillary-lymphatic invasion with outcome in patients with renal cell carcinoma.
Eisenberg MS; Cheville JC; Thompson RH; Kaushik D; Lohse CM; Boorjian SA; Costello BA; Leibovich BC
J Urol; 2013 Jul; 190(1):37-43. PubMed ID: 23353044
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma.
Yoo C; Song C; Hong JH; Kim CS; Ahn H
J Urol; 2008 Aug; 180(2):486-91; discussion 491. PubMed ID: 18550101
[TBL] [Abstract][Full Text] [Related]
8. Metastatic renal cell carcinoma with concurrent inferior vena caval invasion: long-term survival after combination therapy with radical nephrectomy, vena caval thrombectomy and postoperative immunotherapy.
Naitoh J; Kaplan A; Dorey F; Figlin R; Belldegrun A
J Urol; 1999 Jul; 162(1):46-50. PubMed ID: 10379737
[TBL] [Abstract][Full Text] [Related]
9. Risk of metastasis for T1a renal cell carcinoma.
Lee H; Lee JK; Kim K; Kwak C; Kim HH; Byun SS; Lee SE; Hong SK
World J Urol; 2016 Apr; 34(4):553-9. PubMed ID: 26245747
[TBL] [Abstract][Full Text] [Related]
10. Renal cell carcinoma in young and old patients--is there a difference?
Thompson RH; Ordonez MA; Iasonos A; Secin FP; Guillonneau B; Russo P; Touijer K
J Urol; 2008 Oct; 180(4):1262-6; discussion 1266. PubMed ID: 18707708
[TBL] [Abstract][Full Text] [Related]
11. Tumor size is associated with malignant potential in renal cell carcinoma cases.
Thompson RH; Kurta JM; Kaag M; Tickoo SK; Kundu S; Katz D; Nogueira L; Reuter VE; Russo P
J Urol; 2009 May; 181(5):2033-6. PubMed ID: 19286217
[TBL] [Abstract][Full Text] [Related]
12. Renal sinus fat invasion in pT3a clear cell renal cell carcinoma affects outcomes of patients without nodal involvement or distant metastases.
Bertini R; Roscigno M; Freschi M; Strada E; Petralia G; Pasta A; Matloob R; Sozzi F; Da Pozzo L; Colombo R; Guazzoni G; Doglioni C; Montorsi F; Rigatti P
J Urol; 2009 May; 181(5):2027-32. PubMed ID: 19286201
[TBL] [Abstract][Full Text] [Related]
13. Cytokine therapy response as a selection criterion for cytoreductive nephrectomy in metastatic renal clear-cell carcinoma of intermediate prognosis. Results and conclusions from a combined analysis.
Bex A; Haanen JB; Vyth-Dreese FA; Horenblas S; de Gast GC
Urol Int; 2008; 80(4):367-71. PubMed ID: 18587246
[TBL] [Abstract][Full Text] [Related]
14. Tumor size predicts synchronous metastatic renal cell carcinoma: implications for surveillance of small renal masses.
Kunkle DA; Crispen PL; Li T; Uzzo RG
J Urol; 2007 May; 177(5):1692-6; discussion 1697. PubMed ID: 17437785
[TBL] [Abstract][Full Text] [Related]
15. Cytoreductive Nephrectomy for Renal Cell Carcinoma with Venous Tumor Thrombus.
Abel EJ; Spiess PE; Margulis V; Master VA; Mann M; Zargar-Shoshtari K; Borregales LD; Sexton WJ; Patil D; Matin SF; Wood CG; Karam JA
J Urol; 2017 Aug; 198(2):281-288. PubMed ID: 28268170
[TBL] [Abstract][Full Text] [Related]
16. The impact of three-dimensional tumor volume on cancer-specific survival for patients with pT1 clear-cell renal cell carcinoma.
Song W; Jeong BC; Seo SI; Jeon SS; Lee HM; Choi HY; Jeon HG
World J Urol; 2016 Jan; 34(1):83-8. PubMed ID: 25981404
[TBL] [Abstract][Full Text] [Related]
17. Tumor size and Fuhrman grade further enhance the prognostic impact of perinephric fat invasion and renal vein extension in T3a staging of renal cell carcinoma.
Chen K; Lee BL; Huang HH; Tan BY; Lee LS; Ng LG; Lau W; Yuen JS
Int J Urol; 2017 Jan; 24(1):51-58. PubMed ID: 27757999
[TBL] [Abstract][Full Text] [Related]
18. Age, tumor size and relative survival of patients with localized renal cell carcinoma: a surveillance, epidemiology and end results analysis.
Scoll BJ; Wong YN; Egleston BL; Kunkle DA; Saad IR; Uzzo RG
J Urol; 2009 Feb; 181(2):506-11. PubMed ID: 19084868
[TBL] [Abstract][Full Text] [Related]
19. Cytoreductive nephrectomy in patients with synchronous metastases from renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium.
Heng DY; Wells JC; Rini BI; Beuselinck B; Lee JL; Knox JJ; Bjarnason GA; Pal SK; Kollmannsberger CK; Yuasa T; Srinivas S; Donskov F; Bamias A; Wood LA; Ernst DS; Agarwal N; Vaishampayan UN; Rha SY; Kim JJ; Choueiri TK
Eur Urol; 2014 Oct; 66(4):704-10. PubMed ID: 24931622
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics and outcomes of patients with recurrence 5 years after nephrectomy for localized renal cell carcinoma.
Adamy A; Chong KT; Chade D; Costaras J; Russo G; Kaag MG; Bernstein M; Motzer RJ; Russo P
J Urol; 2011 Feb; 185(2):433-8. PubMed ID: 21167521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
